HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nicotine Replacement Therapy Not Linked To Stillbirths, Study Finds

This article was originally published in The Tan Sheet

Executive Summary

There is no association between the use of nicotine replacement therapy products and the risk of stillbirths among pregnant women, according to a Danish Ministry of Health study

You may also be interested in...



Make Smoking Cessation OTCs As Available As Cigarettes – Petition

A citizen petition asking FDA to allow OTC nicotine replacement therapy products to be sold wherever cigarettes are sold and at similar prices has been filed by the New York State Department of Health

UK Clears Nicotine Replacement Therapy For Teens, Pregnant Women – MHRA

The UK health authority plans to extend the availability of nicotine replacement therapy in the new year to new patient populations, including teenagers and pregnant women

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel